WO2026138970 - MEDICAL USE OF COMPOUND A OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
National phase entry is expected:
Publication Number
WO/2026/138970
Publication Date
02.07.2026
International Application No.
PCT/CN2025/145648
International Filing Date
25.12.2025
Title **
[English]
MEDICAL USE OF COMPOUND A OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
[French]
UTILISATION MÉDICALE D'UN COMPOSÉ A OU D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI
[Chinese]
一种化合物A或其药学上可接受的盐的医药用途
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
XIAO, Ying
LI, Hongchao
XING, Wei
LU, Yinsuo
YANG, Zhao
XING, Yan
Priority Data
PCT/CN2024/142727
26.12.2024
CN
202510866022.4
25.06.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1641 | |
| EPO | Filing, Examination, Granting | 11440 | |
| Japan | Filing, Examination, Granting | 2025 | |
| South Korea | Filing, Examination, Granting | 1814 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,660
Contact Us
Abstract[English]
The present invention relates to the technical field of chemicals, provides a medical use of a compound A or a pharmaceutically acceptable salt thereof, and specifically relates to a use of the compound A or the pharmaceutically acceptable salt thereof in preparation of a drug for preventing or treating nephropathy-related diseases.[French]
La présente invention relève du domaine technique des produits chimiques, et concerne une utilisation médicale d'un composé A ou d'un sel pharmaceutiquement acceptable de celui-ci, et plus particulièrement une utilisation du composé A ou du sel pharmaceutiquement acceptable de celui-ci dans la préparation d'un médicament pour la prévention ou le traitement de maladies associées à la néphropathie.[Chinese]
本发明属于化学药物技术领域，提供了一种化合物A或其药学上可接受的盐的医药用途，具体涉及一种化合物A或其药学上可接受的盐在制备用于预防或治疗与肾病相关疾病的药物中的用途。